According to the algorithm of population screening for prostate cancer in Kazakhstan at the level of total PSA of 4–10 ng/ml, and PHI ≥ 25, a needle biopsy of the prostate should be carried out, whereas at the level of PHI <25 a dynamic control should be maintained. This evidence concerns the gene KLK3 and prostate cancer.